198HO02240 RANGPUR

Print/PDF
Registration Name CRISTELLA RANGPUR-ET
Registration Number HOITA019991987851
Primary NAAB Code 198HO02240
Secondary Code(s) 598HO02240
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 3/10/2020
aAa 243165
DMS -
GFI 12.9%
Genetic Codes * TD TC TL TY TV TP TR TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire S-S-I BG FRZZLD RIVETING-ET
MGS MR RUBICON DYNASTY-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ 530, 80% R CM$ 557
NM Percentile 53% FM$ 469
GTPI 2855 GM$ 532
PRODUCTION TRAITS
153 Dtrs 110 herds 0 % US 88% R
Milk 32 Fat, % 19 , +0.07%
SCS 2.76, 87% R Protein, % 17 , +0.06%
Feed Saved 316 , 56% R Milking Speed 6.87 , 67% R
Health & Fertility
Productive Life 4.2      82% R Mastitis 4.2      76% R
Heifer Livability 0.1       59% R Metritis 0.4      73% R
Livability 4.7      79% R D. Abom 0.4      75% R
DPR 1.2      83% R Ketosis 1.3      73% R
HCR 2.0      79% R R. Placenta -0.3      73% R
FSC 5.3      78% R Milk Fever 0.1      67% R
CCR 2.7      82% R
SCR -        -
DIA -0.5      46% R
RSP -0.7      55% R
Calving Traits
Sire CE 1.3      41% R 221 Obs
Daughter CE 1.5      33% R 0 Obs, 80 Dtrs
Sire SB 3.9      39% R 397 Obs
Daughter SB 3.4      39% R 0 Obs, Dtrs
Gestation Length -1.5      77% R 0 Obs, 0 Dtrs
Early First Calving 3.4      77% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
101 Dtrs 68 herds 87% R
PTA Type -0.48 UDC -0.07
HCC -0.05 BWC -0.92
FLC -0.40
Linear Traits
Stature -1.15
Short
Strength -1.22
Weak
Body Depth -1.54
Shallow
Dairy Form -0.84
Closed
Rump Angle 1.27
Sloped
Thurl Width -0.31
Narrow
Rear Legs-Side View 0.89
Curved
Rear Legs-Rear View -0.56
H.-in
Foot Angle -1.20
Low
Feet & Legs Score -0.56
Low
F.U. Attachment -0.18
Weak
Rear Udder Height -0.15
Low
Rear Udder Width -0.34
Narrow
Udder Cleft -0.83
Weak
Udder Depth 0.05
Shallow
Front Teat Placement -0.22
Wide
Rear Teat Placement -0.50
Wide
Teat Length -1.30
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO